Fredeswinda Romero-Bueno
Hospital Universitario Fundación Jiménez Díaz(ES)Universidad Autónoma de Madrid(ES)
Publications by Year
Research Areas
Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis, Inflammatory Myopathies and Dermatomyositis, Ocular Diseases and Behçet’s Syndrome, Systemic Sclerosis and Related Diseases, COVID-19 Clinical Research Studies
Most-Cited Works
- → Recommendations for the treatment of anti-melanoma differentiation-associated gene 5-positive dermatomyositis-associated rapidly progressive interstitial lung disease(2020)175 cited
- → Anti-TNF- therapy in patients with refractory uveitis due to Behcet's disease: a 1-year follow-up study of 124 patients(2014)122 cited
- → Comparative Study of Infliximab Versus Adalimumab in Refractory Uveitis due to Behçet's Disease: National Multicenter Study of 177 Cases(2019)106 cited
- → Efficacy of rituximab in slowing down progression of rheumatoid arthritis–related interstitial lung disease: data from the NEREA Registry(2019)88 cited
- → Pharmacologic Treatment of Anti-MDA5 Rapidly Progressive Interstitial Lung Disease(2021)49 cited
- → Why choose cyclosporin A as first-line therapy in COVID-19 pneumonia(2020)40 cited